Transposon sequencing analyses reveal that among genomically diverse clinical Mycobacterium intracellulare strains and the type strain, 131 genes were comprehensively identified as universal essential ...

Japan's Shionogi has added to its antibiotics pipeline by partnering a preclinical-stage candidate from Swiss biotech BioVersys, which specialises in drugs that can counter antimicrobial resistance ...

Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been ...

Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting bacteria that cause tuberculosis. The team have produced a compound that inhibits ...

Treatment for mycobacterium avium complex (MAC) depends on where the infection is. Your doctor will also consider how serious your symptoms are and other medical conditions you may have. Here’s what ...

Paratuberculosis, a chronic non-treatable enteritis of ruminants caused by Mycobacterium avium subspecies paratuberculosis (MAP), causes economic loss to dairy farmers worldwide and is characterized ...

Background: Mycobacterium avium (M. avium) is a nontuberculous mycobacterium (NTM) that can cause pulmonary and extrapulmonary infections mostly in immunocompromised individuals, such as those with ...

Drug maker Insmed (INSM) is rising 6% today after it released on Friday afternoon its estimate of the revenue generated by its Arikayce drug in 2024. The company also provided 2025 sales guidance for ...

Mycobacterium avium complex (MAC) is a group of bacteria related to tuberculosis. These germs are very common in food, water, and soil. Almost everyone has them in their bodies. When you have a strong ...

AN2 Therapeutics is rethinking its business in response to lackluster midphase data, vowing to lay off half its employees and stop a phase 3 study as part of a pivot to early-stage projects. The ...